Farallon Capital Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Farallon Capital Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,278,900	Closed	-$277M	–	390
2021 Q1	$277M	Buy	+1,278,900	New	+$240M	1.38%	29
2017 Q2	–	Sell	-250,000	Closed	-$30.2M	–	89
2017 Q1	$30.2M	Buy	250,000 +102,072	+69%	+$12.5M	0.33%	50
2016 Q4	$16.5M	Buy	147,928 +116,928	+377%	+$14.1M	0.19%	49
2016 Q3	$4.12M	Sell	31,000 -9,000	-23%	-$860K	0.06%	59
2016 Q2	$3.66M	Sell	40,000 -20,000	-33%	-$1.68M	0.05%	60
2016 Q1	$4.33M	Buy	+60,000	New	+$3.29M	0.04%	69
2015 Q3	–	Sell	-60,000	Closed	-$7.37M	–	102
2015 Q2	$7.37M	Buy	+60,000	New	+$6.81M	0.1%	74
2014 Q4	–	Sell	-244,000	Closed	-$19.7M	–	102
2014 Q3	$19.7M	Sell	244,000 -108,500	-31%	-$9.6M	0.32%	59
2014 Q2	$37.8M	Sell	352,500 -311,500	-47%	-$21.7M	0.55%	46
2014 Q1	$39.4M	Buy	664,000 +80,000	+14%	+$4.76M	0.77%	35
2013 Q4	$24.3M	Hold	584,000	–	–	0.5%	48
2013 Q3	$10.1M	Buy	584,000 +24,000	+4%	+$276K	0.21%	54
2013 Q2	$4.93M	Buy	+560,000	New	+$4.96M	0.09%	67

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Farallon Capital Management's GWPH Position: Q2 2021 in Review

Farallon Capital Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 1,278,900 shares — an estimated $277M sold.

Farallon Capital Management first reported a position in GWPH in Q2 2013 and held it in 13 quarters. The position peaked at $277M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Farallon Capital Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Farallon Capital Management sold 1,278,900 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $277M.
Farallon Capital Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2013 and held it in 13 quarters.
Farallon Capital Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $277M in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Farallon Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.